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1Transcatheter aortic valve replacement (TAVR) is increas-ingly used to treat patients with severe aortic stenosis who 
are deemed inoperable or at high risk for surgical aortic valve 
replacement.1 Recent clinical data demonstrate that TAVR is 
also a good alternative for surgical aortic valve replacement in 
intermediate-risk patients,2 resulting in a further expansion of 
the indication for TAVR.3
At variance with surgical aortic valve replacement, con-
duction abnormalities (left bundle branch block [LBBB], 
high-degree atrioventricular block [AVB]) frequently occur 
after TAVR and remain a major clinical limitation as it may 
lead to permanent pacemaker implantation.4
Despite the fact that patient-, procedure-, and device-
related variables have been shown to be associated with an 
increase of conduction abnormalities after TAVR, the under-
lying mechanism is not completely clear.4 Some authors have 
mentioned that pressure generated by the prosthetic valve 
frame on the atrioventricular conduction pathway may be an 
important driver of new conduction abnormalities, although 
other mechanisms may play a role as well.5–8
Therefore, the aim of this study was to investigate to 
what extent mechanical pressure, assessed by patient-spe-
cific computer simulations, affects the conduction system 
after TAVR.
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Background—The extent to which pressure generated by the valve on the aortic root plays a role in the genesis of conduction 
abnormalities after transcatheter aortic valve replacement (TAVR) is unknown. This study elucidates the role of contact 
pressure and contact pressure area in the development of conduction abnormalities after TAVR using patient-specific 
computer simulations.
Methods and Results—Finite-element computer simulations were performed to simulate TAVR of 112 patients who had 
undergone TAVR with the self-expanding CoreValve/Evolut R valve. On the basis of preoperative multi-slice computed 
tomography, a patient-specific region of the aortic root containing the atrioventricular conduction system was determined 
by identifying the membranous septum. Contact pressure and contact pressure index (percentage of area subjected to 
pressure) were quantified and compared in patients with and without new conduction abnormalities. Sixty-two patients 
(55%) developed a new left bundle branch block or a high-degree atrioventricular block after TAVR. Maximum contact 
pressure and contact pressure index (median [interquartile range]) were significantly higher in patients with compared 
with those without new conduction abnormalities (0.51 MPa [0.43–0.70 MPa] and 33% [22%–44%], respectively, versus 
0.29 MPa [0.06–0.50 MPa] and 12% [1%–28%]). By multivariable regression analysis, only maximum contact pressure 
(odds ratio, 1.35; confidence interval, 1.1–1.7; P=0.01) and contact pressure index (odds ratio, 1.52; confidence interval, 
1.1–2.1; P=0.01) were identified as independent predictors for conduction abnormalities, but not implantation depth.
Conclusions—Patient-specific computer simulations revealed that maximum contact pressure and contact pressure 
index are both associated with new conduction abnormalities after CoreValve/Evolut R implantation and can predict 
which patient will have conduction abnormalities.  (Circ Cardiovasc Interv. 2018;11:e005344. DOI: 10.1161/
CIRCINTERVENTIONS.117.005344.)
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Methods
The data, analytic methods, and study materials will not be made 
available to other researchers for purposes of reproducing the results 
or replicating the procedure.
Study Population
The study population consists of 112 patients who underwent TAVR 
on native valves (ie, no valve-in-valve) using either the self-expand-
ing CoreValve or an Evolut R transcatheter heart valve (Medtronic, 
MN) because of severe aortic stenosis (Table 1). All patients had un-
dergone preoperative multi-slice computed tomography (MSCT) for 
sizing and that was of sufficient quality to allow computer simulation 
as previously described.9,10 MSCT in-plane and through-plane resolu-
tion ranged from 0.32 to 0.97 mm/pixel, slice increment from 0.25 to 
0.8 mm, and slice thickness from 0.5 to 1.5 mm.
This study was approved by the institutional review committee, 
and patients were selected for TAVR by the multidisciplinary Heart 
Team at the participating hospital. All patients were informed about 
the procedure and provided with informed written consent for the 
procedure and data collection.
Computer Simulations
Preoperative MSCT was used to generate patient-specific 3-dimen-
sional models of the native aortic root anatomy that included the left 
ventricular outflow tract (LVOT), the calcified native leaflets, and 
the ascending aorta, using image segmentation techniques (Mimics 
v18.0; Materialise, Leuven, Belgium). The aortic wall and the leaf-
lets were assumed to have a constant thickness of 2 mm and 1.5 
mm, respectively.9 Subsequently, virtual implantation of Medtronic 
CoreValve and CoreValve Evolut R systems in these aortic models 
was retrospectively performed using finite-element computer mod-
eling (Abaqus/Explicit v6.12; Dassault Systèmes, Paris, France) as 
previously described.9 In brief, CoreValve and CoreValve Evolut R 
frames were reconstructed from optical microscopy measurements 
and micro-computed tomography images, whereas the mechanical 
characteristics of the Nitinol frame were derived from in vitro radial 
compression tests at body temperature. The mechanical properties 
of the different tissues in the computer model were calibrated by an 
iterative back-calculation method using both pre- and postoperative 
MSCT images.9 The aortic tissue was modeled with elastic material 
properties (E=2 MPa; ν=0.45), and spring elements were added to 
incorporate the impact of surrounding structures in the model. The 
leaflets were assumed to be linear elastic (E=0.6 MPa; ν=0.3), where-
as calcifications were modeled using a stiffer elastic material with 
perfect plasticity (E=4 MPa; ν=0.3; Yield stress=0.6 MPa). General 
contact with finite sliding between all the surfaces was applied with 
hard contact properties to prevent penetrations along the normal di-
rection. A friction coefficient of 0.7 was used to model the interaction 
between the frame and the aortic model.
These computer simulations allow to assess device–host interac-
tion and, thus, device and aortic wall deformation and the resulting 
contact pressure exerted by the frame on the surrounding anatomy. 
During the computer simulations, all steps of the clinical implanta-
tion consisting of pre-dilatation (ie, balloon size), valve size, depth 
WHAT IS KNOWN
• Conduction abnormalities frequently occur during 
transcatheter aortic valve replacement as a result of 
(temporary or permanent) contact injury to the atrio-
ventricular conduction tissue.
• The degree of injury most likely differs between 
patients and procedures.
WHAT THE STUDY ADDS
• The computational simulations performed in this 
study suggest that contact pressure and area sub-
jected to contact pressure, but not the depth of valve 
implantation, are associated with the occurrence of 
new conduction abnormalities.





P ValueYes (n=62) No (n=50)
Baseline characteristics
  Female sex 56 (50) 31 (50) 25 (50) >0.99














  Annular diameter, 
mm*
23.9±1.8 24.1±1.9 23.7±1.7 0.19
  Height, cm 164.2±8.1 163.9±8.4 164.7±7.8 0.64
  Weight, kg 71.9±12.1 72.0±12.5 71.7±11.8 0.92
  BSA, m2 1.8±0.2 1.8±0.2 1.8±0.2 0.73
  Pre–RBBB 5 (4) 3 (5) 2 (4) 0.83
  IVS calcifications† 12 (11) 5 (8) 7 (14) 0.31
IBMS characteristics
  IBMS length, mm 10.2±3.7 10.5±3.9 9.8±3.3 0.29
  IBMS angle, deg 18.8±15.2 19.6±14.7 17.7±15.9 0.52
  p
1
 depth, mm 5.5±3.2 5.2±3.5 5.8±2.9 0.32
  p
3
 depth, mm 2.2±2.4 1.7±2.2 2.8±2.5 0.02
Procedural characteristics
  Implantation depth, 
mm‡
7.2±3.5 8.4±3.2 5.8±3.2 <0.001
  Device type 0.07
   CoreValve (CV) 95 (85) 56 (90) 39 (78)  
   Evolut R (CVER) 17 (15) 6 (10) 11 (22)  
  Device size 0.37
   CV26 30 (27) 17 (28) 13 (26)  
   CV29 60 (54) 35 (57) 25 (50)  
   CV31 5 (4) 4 (6) 1 (2)  
   CVER26 6 (5) 2 (3) 4 (8)  
   CVER29 11 (10) 4 (6) 7 (14)  
  Sizing index§ 1.18±0.1 1.17±0.1 1.19±0.1 0.29
Values are mean±SD, median [interquartile range] or n (%). BSA indicates 
body surface area; CV, CoreValve; CVER, CoreValve Evolut R; IBMS, inferior 
border of the membranous septum; IVS, interventricular septum; NCC, 
noncoronary cusp; and RBBB, right bundle branch block.
*Perimeter-based diameter=annular perimeter/π.
†Presence of calcifications in the IVS (plane perpendicular to the annulus).
‡Implantation depth assessed in postoperative angiograms: distance from 
the aortic annular plane on the NCC side to the deepest level of the most 
proximal edge of the device frame.
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of implantation, and post-dilatation (ie, balloon size) if applied were 
respected, as previously described in 2 studies in which the software 
was validated for the assessment of frame geometry and expansion, 
calcium displacement, and paravalvular leakage.9,10 Device reposi-
tioning of the Evolut R was not integrated in the model, but the final 
depth of implantation at the noncoronary cusp (NCC) and left coro-
nary cusp was matched with the actual depth of implantation derived 
from contrast angiography performed immediately after TAVR, using 
the same projection angle.
Pressure Analysis
From each finite-element simulation, the force exerted on the recipi-
ent anatomy was extracted. For the purpose of this study (ie, rela-
tionship between contact pressure and new conduction abnormalities 
after TAVR), the region of the LVOT that contains the atrioventricular 
conduction system was defined as the region of interest. At that re-
gion, (1) maximum contact pressure and (2) contact pressure index 
(ie, the percentage of this region of interest subjected to contact pres-
sure) were calculated (Figures 1, 2, and 3).
The region of interest for the contact pressure analysis was select-
ed on each 3-dimensional aortic root model, starting from the infe-
rior border of the membranous septum (IBMS), as this represents an 
anatomic surrogate for the surfacing of the His bundle and the transi-
tion to the left bundle branch.11–13 To identify the IBMS, 3 dedicated 
landmarks were determined on the preoperative MSCT images at the 
transition between the interventricular membranous septum (MS) and 
muscular septum14 in the resliced view perpendicular to the annular 
plane (Figure 1). Two of these landmarks were selected at the begin-
ning and at the end of the IBMS, namely p1 and p3, with p1 closer to 
the NCC and p3 closer to the right coronary cusp (RCC). An addi-
tional point (p2) was selected in between to better track the course of 
the IBMS as this is often not a straight line (Figure 1A). If an abrupt 
change in the IBMS was seen when scrolling through the MSCT im-
ages between p1 and p3, p2 was chosen at that location. On the basis of 
anatomic findings,11,15 the region of interest for the contact pressure 
analysis was defined by the area between the IBMS (extended toward 
the RCC by a 25° angle) and the plane 15 mm below the annulus 
(Figure 1B and 1C), to ensure the inclusion of the proximal part of 
the left bundle branch.
The effect of frame rotation on contact pressure and contact pres-
sure index was taken into account by simulating for each patient 3 
different rotations of the frame: starting from a reference position the 
frame was rotated with 6° and 12°. The resulting maximum contact 
pressure and contact pressure index for these different rotations were 
then averaged per patient.
Figure 1. Identification of anatomic land-
marks and computer modeling workflow. 
A, Identification of inferior border of the 
membranous septum (IBMS) in the preop-
erative multi-slice computed tomography 
(MSCT) images through 3 consecu-
tive landmarks (p1, p2, p3, in red); (B, C) 
patient-specific 3-dimensional aortic 
model with, in black, the selected region 
of interest in vicinity of the atrioventricular 
conduction system from a frontal view 
(B) and from a top view (C); (D) virtual 
implantation of the Medtronic CoreValve 
device at the same implantation depth as 
done in the real procedure. NCC indicates 
noncoronary cusp; and RCC, right coro-
nary cusp.
Figure 2. Anatomic variability—IBMS is 
represented by 3 red landmarks. A, Illus-
tration of the inferior border of the mem-
branous septum (IBMS)–related anatomic 
measurements: IBMS length (l)—distance 
between landmarks p1 and p3, IBMS loca-
tion (d1 and d3)—distance of landmarks 
p1 and p3 from the annular plane, IBMS 
orientation (α)—angle between the seg-
ment connecting p1 and p3 and the annu-
lar plane. B, Representative illustration of 
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Besides the contact pressure analysis, the anatomic variability of 
the length, location, and orientation of the IBMS was investigated 
(Figure 2A). The length of the IBMS (l) was defined as the distance 
between the first (p1) and the last (p3) selected landmarks, the location 
of the IBMS was defined as the relative distance of points p1 (d1) and 
p3 (d3) to the aortic annular plane, and the orientation of the IBMS 
was described by the angle α between the segment connecting p1 and 
p3, and the aortic annular plane.
Statistical Analysis
Continuous variables are expressed as mean±SD or median [inter-
quartile range], stratified by the occurrence of new TAVR-related 
conduction abnormalities, and compared using the Student t test 
or Mann–Whitney–Wilcoxon test depending on the variable dis-
tribution. Discrete variables are expressed as percentage and com-
pared using the χ2 or the Fisher exact test where appropriate. The 
nonparametric Friedman test was used to analyze differences in 
maximum contact pressure and contact pressure index between 3 
different rotations of the device. Anatomic baseline characteristics 
and procedural parameters that were considered relevant for the de-
velopment of conduction abnormalities were analyzed together with 
the maximum contact pressure and contact pressure index. Only 
variables yielding a P value <0.1 in the univariable analysis were 
included in the stepwise logistic regression (backward likelihood 
ratio) analysis. Only for significant results (P<0.05), receiver-op-
erating characteristics curves were generated to find optimal cutoff 
values (Youden index criterion16), and sensitivity, specificity, posi-
tive predictive value, negative predicted value, and accuracy were 
calculated. Correlation between implantation depth, maximum 
contact pressure and contact pressure index was also analyzed, and 
results are reported in the Data Supplement. Statistical analysis was 
performed with the statistical software package SPSS version 22.0 
(IBM Corporation, New York).
Results
Baseline patient- and procedure-related characteristics are 
summarized in Table 1. Sixty-two patients (55%) developed 
new conduction abnormalities after TAVR: LBBB or high-
degree AVB (second-degree AVB Mobitz 2 or third-degree 
AVB). A higher number of patients developed new conduc-
tion abnormalities after implantation of a CoreValve com-
pared with those who received an Evolut R (59% versus 35%). 
There were no other differences between patients with and 
without a new conduction abnormality, except for a deeper 
implantation of the valve in the LVOT (8.4 versus 5.8 mm; 
P<0.001) and a more shallow position of the IBMS at p3 (1.7 
versus 2.8 mm) in the group with conduction abnormalities. 
An example of the variations in anatomy of the IBMS is illus-
trated in Figure 2.
Contact Pressure on the LVOT in the Region of 
Interest
The nonparametric Friedman test showed no statistical dif-
ference in maximum contact pressure and contact pressure 
index between the 3 device rotations (P=0.073 and P=0.698, 
respectively). Maximum pressure and contact pressure index 
were both significantly higher in patients with a new conduc-
tion abnormality after TAVR (P<0.001; Table 2). The median 
value of maximum contact pressure (0.51 MPa [0.43–0.70 
MPa]) and contact pressure index (33% [22%–44%]) was 
2- to 3-fold higher in patients with a new conduction abnor-
mality compared with patients without a new conduction 
abnormality (0.29 MPa [0.06–0.50 MPa] and 12% [1%–
28%]; Figure 4). In the majority of patients (89%), the maxi-
mum contact pressure was observed in the upper half of the 
region of interest.
Computer simulation results in a patient without and with 
a new conduction abnormality with comparable depth of 
implantation of the device are shown in Figure 3. In the patient 
without a new conduction abnormality, a low maximum con-
tact pressure (≤0.11 MPa) in the vicinity of the conduction 
system (region of interest delimited by the black border) was 
observed. Conversely, the patient who developed a new AVB 
Table 2. Simulation Results
Parameters All Patients (n=112)
Conduction Abnormalities
P ValueYes (n=62) No (n=50)
Maximum pressure [MPa] 0.46 [0.26–0.62] 0.51 [0.43–0.70] 0.29 [0.06–0.50] <0.001
Contact pressure index [%] 26 [13–40] 33 [22–44] 12 [1–28] <0.001
Values are mean±SD, median [interquartile range] or n (%).
Figure 3. Contact pressure: representative examples. Representative example of contact pressure observed on the aortic root areas 
where the aortic root is in contact and interacts with calcifications and device frame (indicated by black arrows). The region of interest is 
delimited by the black line. A, Case without a new transcatheter aortic valve replacement (TAVR)–induced conduction abnormality: maxi-
mum contact pressure=0.11 MPa and contact pressure index=20%. B, Case with new TAVR-induced high-degree atrioventricular block 
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experienced high contact pressure within the region of inter-
est (up to 0.85 MPa) and an extended area of contact (contact 
pressure index of 29%).
Interestingly, not all the models showed contact between 
the valve frame and the region of interest. Figure 5 illustrates 3 
patients where no contact was observed in the region of inter-
est because of a large calcium nodule precluding apposition 
of the frame (Figure 5A), of an anatomic low position of the 
IBMS (Figure 5B), and of a large LVOT resulting in malap-
position of the frame (Figure 5C).
The multivariable regression analysis identified maxi-
mum contact pressure (odds ratio, 1.35; confidence interval, 
1.1–1.7; P=0.01) and contact pressure index (odds ratio, 1.52; 
confidence interval, 1.1–2.1; P=0.01) as the only independent 
predictors of conduction abnormalities (Table 3).
Receiver-operating characteristics curve analysis 
(Figure 6) revealed an area under the curve of 0.76 and 0.79 
for maximum contact pressure and contact pressure index, 
respectively. A cutoff value of 0.39 MPa for the maximum 
contact pressure ensured a sensitivity, specificity, positive pre-
dictive value, negative predicted value, and accuracy of 85%, 
64%, 75%, 78% and 76%, respectively. This was 95%, 54%, 
72%, 90%, and 77%, respectively, for a contact pressure index 
of 14%. The accuracy of prediction was further increased 
when combining both contact pressure parameters (Figure 7). 
Fifty-three patients (79%) with a maximum contact pressure 
>0.39 MPa and a contact pressure index >14% developed a 
new conduction abnormality. In case of a maximum contact 
pressure <0.39 MPa and a contact pressure index <14%, 23 
patients (88%) did not experience new conduction abnormali-
ties. Four patients with a maximum contact pressure >0.39 
MPa and a contact pressure index <14% (ie, small area of high 
contact pressure) did not develop conduction abnormalities, 
whereas 6 patients (40%) with a low maximum contact pres-
sure and contact pressure index >14% developed new conduc-
tion abnormalities.
Discussion
The main goal of this study was to investigate the relation 
between the mechanical pressure generated by the pros-
thetic valve frame on the aortic root at the site of the atrio-
ventricular conduction tissue and the development of new 
conduction abnormalities after TAVR. Using patient-specific 
computer simulations, maximum contact pressure and con-
tact pressure index were both assessed. The impact of device 
rotation on the contact pressure within the region of interest 
was also evaluated, but no significant difference on the varia-
tions of both parameters because of the device rotations was 
observed. Both simulation-based parameters were associated 
with new conduction abnormalities (LBBB and high-degree 
AVB) after implantation of a self-expanding valve. Of note, 
the multivariable analysis indicated that contact pressure, but 
not implantation depth, is the driving force of the develop-
ment of new conduction abnormalities. Yet it remains diffi-
cult to elucidate whether pressure levels or relative area is the 
overriding factor. In addition, cutoff values were identified 
Figure 4. Histograms and box plot diagrams of valve implantation depth, maximum contact pressure, and contact pressure index. 
Upper, Distribution of valve implantation depth (left), maximum contact pressure (middle), and contact pressure index (right) in compari-
son to a normal probability curve (black curve). Lower, Box plot diagrams of valve implantation depth (P<0.001, left), maximum contact 
pressure (P<0.001, middle), and contact pressure index (P<0.001, right) in patients with and without conduction abnormalities. Extreme 
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that could discern patients who did and did not develop new 
conduction abnormalities after TAVR.
On the basis of the preoperative MSCT, anatomic land-
marks were identified to define a patient-specific region on 
the LVOT in which the contact pressure was evaluated. The 
definition of this region is based on the consideration that 
the His bundle is located at (or slightly below) the transition 
between the interventricular MS and muscular septum in at 
least 80% of the cases.13 Three-dimensional measurements 
of the IBMS revealed large anatomic variability within the 
studied population in terms of location, orientation, and 
length of the IBMS. In our analysis, the IBMS was located 
below the annular plane on the NCC side and extended 
toward the RCC. In about 13% of the cases, the landmark 
p3 was found to be superior to the annular plane, meaning 
that the distal part of the IBMS intersected the interleaflet 
triangle between NCC and RCC. A representative example 
is shown in Figure 8. These findings are in accordance with 
those of Kawashima and Sato15 (2014) who also found the 
MS to be located between the NCC and the RCC (frequently 
located on the RCC side), with reaching the annular plane 
in about 80% of the cases. Irrespective to the interindividual 
variability of the precise relationship between the MS and 
the conduction tissue, this area is susceptible to injury dur-
ing TAVR. In particular, the position of the IBMS at the RCC 
side (depth of p3) was found to be inversely associated with 
risk of new conduction abnormalities; however, the multi-
variable analysis did not show it to be an independent predic-
tor of new conduction abnormalities.
Several studies consistently revealed the relation 
between a too deep implantation of the prosthesis and the 
occurrence of new-onset LBBB and permanent pacemaker 
implantation.17–21 In our study, such correlation emerged in 
the univariable analysis, but it did not show to be statistically 
significant in the subsequent multivariable analysis. The 
findings of this study are not in disagreement with those who 
focused on the role of depth of implantation because this 
study incorporated both depth of implantation and contact 
pressure and contact pressure area. Depth of implantation 
and area of contact pressure are intrinsically related to one 
another. This study merely indicates that the degree of pres-
sure and area of contact pressure are more important than 
the depth of implantation by itself, which is from a patho-
physiologic perspective a logic finding. Although a high 
implantation is nowadays recommended to avoid conduc-
tion abnormalities, the findings of this study indicate that 
the optimal implantation depth is patient specific given the 
anatomic variability of the MS. General implantation depth 
guidelines may not lead to the best clinical outcome for 
each individual. This is in agreement with the recent work 
of Hamdan et al14 who identified the 2-dimensional MSCT-
based distance from the IBMS to the annular plane and the 
difference between this parameter and the device implan-
tation depth as predictors of high-degree AVB and perma-
nent pacemaker implantation. The results of our anatomic 
Figure 5. Representative cases with no contact within the region 
of interest. A, Large valve calcification (blue arrow) that deter-
mines underexpansion of the frame (black arrow); (B) anatomic 
low position of the inferior border of the membranous septum 
(IBMS); (C) large left ventricular outflow tract (LVOT) and bad 
apposition of the valve frame with the aortic wall.
Table 3. Results of the Logistic Regression for Association 









 depth, mm 0.017 … … …
Device type 0.071 … … …
Implantation depth, mm <0.001 … … …
Maximum pressure, MPa <0.001 0.010 1.35 1.1–1.7
Contact pressure index, % <0.001 0.013 1.52 1.1–2.1
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analysis of the IBMS (eg, the distance from the IBMS to the 
annular plane varies along the course of the IBMS) indicate, 
however, that a single 2-dimensional measurement may not 
fully describe this structure.
Given the above and in line with the demand from soci-
ety and authorities to move to patient-specific treatment to 
enhance safety and efficacy of treatment, thereby, reduc-
ing costs, this and previous works on computer simulations 
indicate the role of patient-specific computer simulations in 
the planning of TAVR offering the physician to choose the 
valve size that best fits the individual patient in addition to the 
optimal depth of implantation.22,23 The findings of this study 
indicate that patient-specific computer simulation pre-TAVR 
may identify which patient will develop a new conduction 
abnormality. Previous works indicated the reliability of spe-
cific computer simulation in the prediction of the presence 
and severity of paravalvular leakage.10 Both outcome mea-
sures can currently be assessed and quantified during the same 
simulation and may, thus, help the physician to choose the 
valve that best fits the individual patient.
Study Limitations
The results of this study only relate to the self-expanding 
CoreValve and Evolut R valves. Its applicability to other 
transcatheter aortic valve systems currently in use should be 
confirmed. Also the effect of device repositioning was not 
taken into account; however, it may be hypothesized that 
especially the final implantation depth is the most determin-
ing factor for inducing conduction abnormalities. Linear 
elastic material properties were used to model the aortic tis-
sue. Although the hyperelastic model better reflects actual 
tissue behavior, the used material parameters accurately 
predict interactions between the aorta and the TAVR device, 
as previously demonstrated.9,24 Future studies should be 
performed to validate the cutoffs identified to discriminate 
between patients who did and did not develop a new con-
duction abnormality. Furthermore, it might be interesting to 
investigate the predictive power of maximum contact pres-
sure and contact pressure index with respect to the type of 
disturbance (LBBB or AVB). Finally, a further quantitative 
analysis of the location of the maximum contact pressure 
within the region of interest during the entire cardiac cycle 
may offer a better insight in the mechanisms of the develop-
ment of new conduction abnormalities after TAVR.
Conclusions
Patient-specific computer simulations revealed that maximum 
contact pressure and contact pressure index are associated 
with new conduction abnormalities after CoreValve/Evolut R 
implantation and can predict which patient will have a con-
duction abnormality after TAVR.
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